proposed expansion of bulk drugs and bulk drug...

27
1 PRE FEASIBILITY REPORT For PROPOSED EXPANSION OF BULK DRUGS AND BULK DRUG INTERMEDIATES IN EXISTING UNIT of M/s. REINE LIFESCIENCE PLOT NO. 5901, KANORIA CHEMICALS ROAD, Nr. PAR DRUGS, GIDC ESTATE, ANKLESHWAR-393002, DIST: BHARUCH (GUJ)

Upload: others

Post on 10-Mar-2020

46 views

Category:

Documents


0 download

TRANSCRIPT

1

PRE FEASIBILITY REPORT

For

PROPOSED EXPANSION OF BULK DRUGS AND BULK DRUG

INTERMEDIATES IN EXISTING UNIT

of

M/s. REINE LIFESCIENCE

PLOT NO. 5901, KANORIA CHEMICALS ROAD,

Nr. PAR DRUGS, GIDC ESTATE, ANKLESHWAR-393002,

DIST: BHARUCH (GUJ)

2

CONTENTS

Sr.

No.

Description Page

No.

1. Executive Summary 3

2. Introduction of the Project/Background information 14

3. Project Description 16

4. Site Analysis 21

5. Planning Brief 23

6. Proposed Infrastructure 24

7. Rehabilitation and resettlement (R & R) Plan 25

8. Project Schedule & Cost Estimates 26

9. Analysis of Proposal (Final Recommendations) 27

3

1.0 EXECUTIVE SUMMARY

1.1 Company Profile

M/s. Reine Lifescience proposes expansion of Bulk Drugs and Bulk drug intermediates in

existing unit located at Plot no. 5901, Kanoria Chemicals Road, Nr. Par Drugs, GIDC Estate,

Ankleshwar-393002, Dist: Bharuch, Gujarat.

1.2 Project Details

1.2.1 Products along with Production Capacity

Sr.

No.

NAME OF PRODUCTS CAS

No.

Existing

Quantity

Additional

Quantity

Total

Quantity

after

Proposed

expansion

(MT/Month)

Group-1

1 Pyrazinamide 98-96-4 3 -- 3

2 Phenyl Butazone 50-33-9 5

70

75

3 L2 OR (4R-cis)-1,1-

dimethylethyl-6-[2-[2-(4-

fluorophenyl)-3-phenyl-4

[(phenylamino)carbonyl]-

1H-pyrrol-1-yl]ethyl]-2,2-

dimethyl-1,3-dioxane-4-

acetate)

125971 -95-1

--

4 L3 OR [(4R-cis)-1,1-

dimethylethyl-6-[2-[2-(4-

fluorophenyl)-3-phenyl-4

[(phenylamino)carbonyl]-

1H-pyrrol-1-yl]ethyl]-2,2-

dimethyl-1,3-dioxane-4-

acetate]

125971 -95-1

5 Phenyl Butazone Calcium 70145 -60-7

6 Bumadizone Calcium 69365 -73-7

7 Metoprolol Tartrate 56392 -17-7

8 Metoprolol succinate 98418-47-41

9 Metoprolol base 37350 -58-6

10 Rosuvastatin Calcium 147098-20-2

11 Racemic 181289 -15-6

12 Sevelamer Carbonate 845273-93-0

13 Benzocaine 94 -09-7

14 Erdosteine 84611-23-4

4

15 Montelukast Sodium 151767-02-1

16 Cosevelam HCl 9064-91-9

17 Diclofenac Sodium 15307-79-6

18 Ambroxol HCl 23828-92-4

Group-2

19 Atovastain calcium 344423-98-9

--

20

20

20 Pregabalin 148553-50-8

21 RCMH 181289-33-8

22 Sevelamer HCl 152751-57-0

23 Phenylephrine HCl 61-76-7

24 Phenylephrine base 59-42-7

25 AAPA 943-80-6

Group-3

26 Polyallylamine HCl 71550-12-4 -- 40 40

27 Polyallylamine 30551-89-4 -- 40 40

28 Allylamine HCl 10017-11-5 -- 40 40

TOTAL 8 210 218

1.3 Raw Material Requirement

List of Raw Materials and Their Capacity

SR. NO. Name of Raw Materials CAPACITY

(MT/Month)

GROUP- 1

1. Phenyl Butazone

1. Hydrazobenzene 0.696

2. N-Butyl diethyl malonate 0.870

3. Sodium methoxide powder 0.239

4. Toluene 0.870

5. Activated carbon 0.017

6. Sodium hydrosulfite 0.043

7. Hyflow 0.043

8. Methanol 3.478

9. Acetic acid 0.565

2. Pyrazinamide

1. 2-Cyano pyrizine 1.11

2. Sodium hydroxide 0.44

3. Methanol 2.22

3. L2 OR (4R-cis)-1,1-dimethylethyl-6-[2-[2-(4-fluorophenyl)-3-phenyl-4

5

[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate)

1. (4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-

dioxane-4-acetate (CAS No. 125971-94-0) 0.58

2. Methanol/Toluene 18.58

3. Ammonia 0.82

4. Raney Nickel 0.23

5. Hydrogen Gas 0.01

6. Cyclohexane 5.29

7. Pivalic acid 0.05

8.

2-[2-(4-Fluorophenyl)-2-oxo-1-phenylethyl]-4-

methyl-3-oxo-N phenylpentanamide (M4) (CAS

No.125971-96-2) 0.88

9. Terbutylmethylether 0.52

10. Isopropyl alcohol 6.47

11. Sodium Hydroxide 0.29

12. Sodium chloride 0.29

13. Sodium bicarbonate 0.29

4.L3 OR [(4R-cis)-1,1-dimethylethyl-6-[2-[2-(4-fluorophenyl)-3-phenyl-4

[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate]

1. 4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-

dioxane-4-acetate (CAS No. 125971-94-0) 0.588

2. Methanol/Toluene 18.588

3. Ammonia 0.824

4. Raney Nickel 0.235

5. Hydrogen Gas 0.012

6. Cyclohexane 5.294

7. Pivalic acid 0.059

8.

2-[2-(4-Fluorophenyl)-2-oxo-1-phenylethyl]-4-

methyl-3-oxo-N phenylpentanamide (M4) (CAS

No.125971-96-2) 0.882

9. Terbutylmethylether 0.529

10. Isopropyl alcohol 6.471

11. Sodium Hydroxide 0.294

12. Sodium chloride 0.294

13. Sodium bicarbonate 0.294

14. Acetone 5.059

5. Phenyl Butazone calcium

6

1. Hydrazobenzene 0.696

2. N-Butyl diethyl malonate 0.870

3. Sodium methoxide powder 0.239

4. Toluene 0.870

5. Activated carbon 0.043

6. Sodium hydrosulfite 0.043

7. Hyflow 0.043

8. Methanol 3.478

9. Acetic acid 0.565

10. Calcium chloride 0.196

11. Sodium hydroxide 0.261

6. Bumadizone calcium

1. Hydrazobenzene 0.696

2. N-Butyl diethyl malonate 0.870

3. Sodium methoxide powder 0.239

4. Toluene/N-Hexane 1.739

5. Activated carbon 0.043

6. Sodium hydrosulfite 0.043

7. Hyflow 0.043

8. Methanol 3.478

9. Acetic acid 0.565

10. Calcium chloride 0.196

11. Sodium hydroxide 0.261

7. Metoprolol tartrate

1. 4-Methoxy ethyl phenol 0.588

2. Epichlorhydrine 0.471

3. Sodium hydroxide 0.176

4. Monoisopropyl amine 1.000

5. Isopropyl alcohol 1.176

6. L(+) Tartraric acid 0.294

7. Acetone 6.471

8. Activated carbon 0.029

8. Metoprolol succinate

1. 4-(2-Methoxyethyl) phenol 0.588

2. Epichlorhydrine 0.471

3. Sodium hydroxide 0.176

7

4. Monoisopropyl amine 1.000

5. Isopropyl alcohol 1.176

9. Metoprolol base

1. 4-(2-Methoxyethyl) phenol 0.588

2. Epichlorhydrine 0.471

3. Sodium hydroxide 0.176

4. Monoisopropyl amine 1.000

5. Isopropyl alcohol 1.176

6. Succinic acid 0.294

7. Acetone 6.471

8. Activated carbon 0.029

10. Rosuvastatin calcium

1.

6-[(1E)-2-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-

[methyl (methylsulfonyl)amino]-5-

pyrimidinyl]ehtenyl]-2,2-Dimethyl-1,3-Dioxane-4-

Acetic acid-1,1-dimethyl ethyl ester (CAS No.289042-

12-2) 1.333

2. Methanol 10.667

3. Toluene 2.667

4. Hydrochloric acid 0.400

5. Sodium Hydroxide 0.400

6. Calcium acetate 0.533

7. Activated carbon 0.067

8. Hyflow 0.067

11. Racemic

1. Cyanoacetate 0.667

2. Isoveraldehyde 1.333

3. Piperidine 0.033

4. Sulphuric acid 6.667

5. Toluene 1.333

6. Urea 1.333

7. Ethyl acetae 1.333

8. Activated carbon 0.067

10. Chloroform 15.000

11. Sodium hydroxide 1.667

12. Hydrochloric acid 3.333

12. Sevelamer Carbonate

8

1. Allylamine 1.000

2. Hydrochloric acid 2.500

3. Catalyst A 0.050

4. Catalyst B 0.050

5. Epichlorhydrine 0.800

6. Sodium hydroxide 1.500

7. Methanol 10.000

8. Sodium bicarbonate 0.500

13. Benzocaine

1. Para amino benzoic acid 1.000

2. Reducer (Ethanol + Acetone) 2.000

3. Sulphuric acid 1.500

4. Toluene 2.000

5. Methanol 4.500

6. Ammonia 3.000

14. Erdosteine

1. Homocysteinethiolactone hydrochloride 1.111

2. Chloracetylchloride 1.667

3. Triethyl amine 1.667

4. Dichloromethane/ Dichloroethane 8.889

5. Thioglycolic acid 0.889

6. Sodium hydroxide 1.111

7. Hydrochloric acid 1.333

8. Methanol 4.444

9. Acetone 4.444

15.Montelukast sodium

1.

2-(2-3S-3,2,7-Chloro-2-

Quinolinyl)ethenylphenyl)3hydroxy propyl)phenyl 2-

propanol [CAS# 142569-70-8] 1.111

2. MercaptomethylCyclopropane Acetic Acid [CAS#

162515-68-6] 0.333

3. Toluene 55.556

4. Acetonitrile 10.000

5. Di iso propyl ethyl amine 1.111

6. Methane sulphonyl chloride 0.333

7. Dimethyl sulfoxide 4.444

8. Sodium methoxidesolution 1.000

9

9. Acetic acid 2.222

10. Sodium hydroxide 1.111

11. Sodium sulphate 1.111

12. sodium bicarbonate 0.289

13. Ethylacetate 2.222

14. Tertiary butyl amine 0.222

15. Petroleum ether 1.667

16. methanol 17.778

17. N-Heptane 1.556

16.Cosevelam HCl

1. Allylamine 1.000

2. Hydrochloric acid 2.500

3. Catalyst A 0.050

4. Catalyst B 0.050

5. Epichlorhydrine 0.800

6. Methanol 20.000

7. Sodium hydroxide 0.500

8. Hydrochloric acid 0.350

9. Bromodecane 0.200

17.Diclofenac sodium

1. 1 -(2,6-dichlorophenyl)-2-indolinone 1.250

2. Sodium hydroxide 0.375

18. Ambroxol HCl

1. 3,5-Dibromo-2-Aminobenzyl alcohol 1.111

2. Trans-4-Amino cyclohexanol 0.444

3. Tetrahydrofuran 3.333

4. Toluene 2.222

5. Sodium borohydride 0.278

6. Methanol 4.444

7. Isopropyl alcohol 3.333

8. Conc. Hydrochloric acid 0.556

GROUP-2

19.Atovastain calcium

1. (4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-

dioxane-4-acetate (CAS No. 125971-94-0) 0.5

2. Methanol/Toluene 18.58

3. Ammonia 0.82

10

4. Raney Nickel 0.23

5. Hydrogen Gas 0.01

6. Cyclohexane/ Cyclohexanone 5.29

7. Pivalic acid 0.05

8.

2-[2-(4-Fluorophenyl)-2-oxo-1-phenylethyl]-4-

methyl-3-oxo-N phenylpentanamide (M4) (CAS

No.125971-96-2) 0.88

9. Terbutylmethylether 0.52

10. Isopropyl alcohol 6.47

11. Sodium Hydroxide 0.29

12. Sodium chloride 0.29

13. Sodium bicarbonate 0.29

14. Acetone 5.05

15. Hydrochloric acid 0.29

16. Activated carbon 0.02

17. Calcium chloride 0.11

18. Calcium acetate 0.11

19. Acetic acid 0.29

20.Pregabalin

1. Cyanoacetate 1.250

2. Isoveraldehyde 2.500

3. Piperidine 0.063

4. Sulphuric acid 12.500

5. Toluene 2.500

6. Urea 2.500

7. Ethyl acetae 2.500

8. Activated carbon 0.125

9. R(+) Phenyl ethyl amine 1.000

10. Chloroform 22.500

11. Sodium hydroxide 2.500

12. Hydrochloric acid 5.000

13. Sodium hypochlorite 7.500

14. Isopropyl alcohol/ N-Butanol 5.000

21.RCMH ( R(-)-3-(Carbamoylmethyl)-5-methyl hexanoic acid)

1. Cyanoacetate 0.833

2. Isoveraldehyde 1.667

3. Piperidine 0.042

11

4. Sulphuric acid 8.333

5. Toluene 1.667

6. Urea 1.667

7. Ethyl acetae 1.667

8. Activated carbon 0.083

9. R(+) Phenyl ethyl amine 0.667

10. Chloroform 15.000

11. Sodium hydroxide 1.667

12. Hydrochloric acid 3.333

22.Sevelamer HCl

1. Allylamine 1.000

2. Hydrochloric acid 2.500

3. Catalyst A 0.050

4. Catalyst B 0.050

5. Epichlorhydrine 0.800

6. Sodium hydroxide 1.500

7. Methanol 10.000

23.Phenylephrine HCl

1. 3-Hydroxyacetophenone 1.250

2. Toluene 6.250

3. Ethylacetate 7.500

4. Bromine 1.125

5. Aluminiumtrichloride 0.063

6. Phenyl ethyl amine 1.875

7. Isopropyl alcohol.HCl 1.250

8. Sodium bicarbonate 0.625

9. Sodium sulphate 0.625

10. Methanol 12.500

11. Palladium charcoal 0.025

12. Isopropyl alcohol 6.250

13. L(+) Tartaric acid 1.250

14. Liq Ammonia 2.500

15. Sulphuric acid 1.250

16. Acetic anhydride 1.250

24.Phenylephrine base

1. 3-Hydroxyacetophenone 1.111

2. Toluene 5.556

12

3. Ethylacetate 6.667

4. Bromine 1.000

5. Aluminiumtrichloride 0.056

6. Phenyl ethyl amine 1.667

7. Isopropyl alcohol.HCl 1.111

8. Sodium bicarbonate 0.556

9. Sodium sulphate 0.556

10. Methanol 11.111

11. Palladium charcoal 0.022

25.AAPA

1. L-Phenylallanine 2.143

2. Nitric acid 1.429

3. Sulfuric acid 8.571

4. Ammonium hydroxide 15.000

5. Hydrochloric acid 2.286

6. Sodium hydroxide 0.243

7. Methanol 42.857

8. 10 % Palladium carbon 0.056

9. Acetic acid 0.357

GROUP-3

26.Polyallylamine HCl

1. Allylamine 0.333

2. Hydrochloric acid 0.833

3. Catalyst A 0.017

4. Catalyst B 0.017

27.Polyallylamine

1. Allylamine 0.333

2. Hydrochloric acid 0.833

3. Catalyst A 0.017

4. Catalyst B 0.017

5. Sodium hydroxide 0.333

6. Methanol 1.667

28.Allylamine HCl

1. Allylamine 0.333

2. Hydrochloric acid 0.833

13

1.4 Water Requirement, Waste Water Generation and Treatment

Total water requirement will be 143 m3/day, which is met through GIDC water supply. Total

waste water generations will be 125 m3/day. Industrial effluent 120 m

3/day in which low COD

Stream 115 m3/day will be treated in ETP consists of primary, secondary & tertiary treatment ,

then it will be sent to CETP (M/s. ETL) for further treatment and Disposal and High COD Stream

5 m3/day will be treated in MEE or it will be sent to CMEE (M/s. ACPTCL) for Disposal. Domestic

Waste water 5 m3/day will be disposed of through the specific tank & Soak Pit System.

1.5 Air Pollution Source and Control Management

There will be flue gas emission from Boiler 0.6 TPH and 1.0 TPH having Multi Cyclone Separator

& Bag Filter as APCM.

1.6 Hazardous Waste

CAT.

NO.

HAZARDOUS

WASTE

Existing

Quantity Additional

Quantity

Total

Quantity METHOD OF DISPOSAL

33.1 Discarded

Containers/Barrels

/liner

300

Nos./Year

3,500

Nos./Year 3,800

Nos./Year

Collection, Storage,

Transportation, Decontamination

& given registered vendors.

5.1 Used Oil 0.005

KL/Year

8.5

KL/Year

8.505

KL/Year Collection, Storage,

Transportation and Sale to

authorized traders.

35.3 Spent Carbon 0.48

MT/Year

900

MT/Year 900.48

MT/Year

Collection, Storage,

Transportation & given for co-

processing cement industries or

Disposal by incineration at

common incinerator of BEIL

28.6

Spent Solvent -- 8400

MT/Month 8400

MT/Month

Collection, Storage, recovered

through in house distillation or

sent for distillation job work to

authorized recycler then reuse in

process.

28.1 Distillation Residue -- 5

MT/Month 5

MT/Month

Collection, Storage,

Transportation & sent to

cement industries for co-

processing or incineration at

common incinerator of BEIL.

14

1.7 Green Belt

Total 5,800 sq. meter land area is available at site; out of this area around 1,900 sq. meter (33%)

area will be developed as greenbelt.

1.8 Power & Fuel Requirements

Power Requirements:

Power required: 125 KV (Existing)

: 500 KV (Proposed)

Source: DGVCL

Fuel Requirements:

Natural Gas: 50 m3/Day (Existing)

Agro Waste: 2 Ton/Day (Additional proposed)

2.0 INTRODUCTION OF THE PROJECT/BACKGROUND INFORMATION

2.1 Identification of the project and project proponent. In case of mining project, a copy of

mining lease/letter of intent should be given.

Identification of the project and project proponent

M/s. Reine Lifescience proposes expansion of Bulk Drugs and Bulk drug intermediates in

existing unit located at Plot no. 5901, Kanoria Chemicals Road, Nr. Par Drugs, GIDC Estate,

Ankleshwar-393002,, Dist: Bharuch, Gujarat.

List of Partners:

Sr.

No.

Name of

Partners

Residential. Address Qualification Phone No.

1. Kalpesh M

Kothiya

A-304, Chandrajyot

Apartment, GIDC, Ankleshwar-

393002.

B.Sc. (Organic

Chemistry)

919825138460,

+912646239556

2. Amish B Shah 12-A, Badrinath Apart,

Shimpoli Road, Near Soniwadi,

Borivali (West)-400092

B.E.

(Electronics)

919820193549,

+912646239556

3. Devang B Shah 12-A, Badrinath Apart,

Shimpoli Road, Near Soniwadi,

Borivali (West)-400092

B. Com 919820193549,

+912646239556

4. Vipul M Kothiya A-304, Chadrajyot Apartment,

GIDC, Ankleshwar-393002

B.Com 919825138460,

+912646239556

15

2.2 Brief description of nature of the Project

Proposed Expansion of Bulk Drugs & Bulk drug Intermediates in existing unit.

2.3 Need for the project and its importance to the country and or region

The demand for products intended to be manufacture is increasing in the country by expanding

this unit, M/s. RL will be able to meet the demand of various products locally. The project will

save forex as certain products import will be reduced. This will also generate direct and indirect

employment opportunity for various levels of people.

2.4 Demands-Supply Gap

Based on our informal survey of the market with our current customers and various traders, we

have found that there is a big potential for the range of the products we are planning. These

products will be an addition to the current product as well as expansion of Bulk Drugs & Bulk

drug Intermediates in existing unit.

2.5 Imports vs. Indigenous production

Based on the current cost of indigenous raw materials and the non availability of some

materials, we will have to import some of the key raw materials as they are not available

indigenously. This will make us very competitive against imported finished products and we will

export of our finished products in the international market.

2.6 Export possibility

We shall explore the possibility of export the products.

2.7 Domestic/Export Markets

Our products have good demand in international market. We shall explore the possibility of

export the products.

16

2.8 Employment Generation (Direct and Indirect) due to project.

M/s. Reine Lifescience will give direct employment to local people based on qualification and

requirement. In addition to direct employment, indirect employment shall generate ancillary

business to some extent for the local population.

3.0 Project Description

3.1 Type of Project including interlinked and interdependent projects, if any.

No interlinked project has been submitt

• Location (map showing general location, specific location and project boundary & project

site layout) with coordinates.

• Map showing general

location.

Project

Site

17

• Specific location and project boundary

• Project Site (Google Map)

18

• Plot Layout

19

3.3 Details of alternate sites considered and the basis of selecting the proposed site,

particularly the environmental considerations gone into should be highlighted.

Looking to the international market demand of the products it was decided by M/s. Reine

Lifescience to expand existing facility.

Major factors involved in the selection of site are listed below:

• Minor site clearance activities shall be carried out.

• The project site is located on level ground, which does not require any major land filling

for area grading work.

• Proximity to Raw Material suppliers.

• Site is very well connected by road and railway.

• Availability of Fuel, Power, Common TSDF, etc.

Modern infrastructure support and amenities at par in other global markets, including:

� Efficient transport facilities.

� Environment-friendly zone.

� Uninterrupted power supply.

3.4 Size or Magnitude of Operation

Please refer Section-1.2.1, Page No. 3.

3.5 Project Description with process details (a schematic diagram/flow chart showing the

project layout, components of the project, etc. should be given)

Please refer Form-I, Annexure-III.

3.6 Raw Material required along with estimated quantity, likely source, marketing area of

final product/s, mode of transport of raw material and Finished product.

For raw material required along with quantity; Please refer Section-1.3, Page No. 4. We shall

procure the raw material as much as possible from domestic market and if there is no

20

availability of any raw material we will import. We shall explore the possibility of export the

finished products.

3.7 Resource optimization/recycling and reuse envisaged in the project, if any, should be

briefly outlined.

After expansion of the unit, Possibility for reuse and recycle will be explored.

3.8 Availability of water its source, energy/power requirement and source should be

given.

Water Source

Total water requirement shall met through GIDC Water Supply.

Power Requirements:

Power required: 125 KV (Existing)

: 500 KV (Proposed)

Source: DGVCL

Fuel Requirements:

Natural Gas: 50 M3/Day (Existing)

Agro Waste : 2 Ton/Day (Additional proposed)

3.9 Quantity of wastes to be generated (liquid and solid) and scheme for their

management/disposal.

Please refer Please refer Form-I, Annexure-IV & VI.

21

3.10 Schematic representations of the feasibility drawing which give information of EIA

purpose.

4.0 Site Analysis

4.1 Connectivity

• Site is very well connected by road

• Availability of fuel, power, Common TSDF, etc.

4.2 Land Form, Land Use and Land Ownership

Land Use will be incorporated in the EIA Study.

RECONNAISSANCE SURVEY OF EXISTING PLANT ANNUAL REPORT

MARKET ASSESSMENT

FINANCIAL REPORT

PROJECT REPORT

INTRODUCTION

MONITORING OF AIR, WATER & SOIL QUALITY & NOISE

LEVELS. DATA ON METEOROLOGY SOCIO-ECONOMIC STATUS

& BASIC AMENITIES. SITE VISITS BY AND INTERVIEWS WITH

LOCALS

BASELINE

ENVIRONMENTAL

STATUS

ENVIRONMENTAL INFORMATION CENTRE

CENTRAL GROUND WATER BOARD

GUJARAT POLLUTION CONTROL BOARD (GPCB)

PUBLIC HEALTH ENGINEERING DEPT.

AGRICULTURE DEPARTMENT

FOREST DEPARTMENT

IRRIGATION DEPARTMENT

EMPLOYMENT EXCHANGE

HEALTH CENTER

CENSUS DEPT.

INDIAN METEOROLOGICAL DEPT.

SOCIOECONOMIC

STATUS &

INFRASTRUCTURE

PROPOSED

PLANT

FACILITY DESCRIPTION

IMPACTS

METHODOLOGY OF

IMPACT

ASSESSMENT

IDENTIFICATION & ASSESSMENT OF IMPACTS

EVALUATION OF IMPACTS BY MATRIX METHOD

SOURCE OF INFORMATION OVERVIEW OF

E. I. A. STUDIES

ACTIVITIES

ENVIRONMENTAL

MANAGEMENT PLAN

DESCRIPTION OF EFFLUENT TREATMENT PLAN, AIR

POLLUTION CONTROL, HAZARDOUS WASTE MANAGEMENT,

GREEN BELT DEVELOPMENT MONITORING PROGRAM

RISK ANALYSIS

STUDIES &

DISASTER

MANAGEMENT PLAN

SAFETY, HEALTH & ENVIRONMENTAL POLICY, GUIDELINES BY

DIRECTOR GENERAL OF FACTORY SAFETY, MINISTRY OF LABOR. CONSEQUENCE ANALYSIS

PREPARATION OF DISASTER MANAGEMENT PLAN

22

4.4 Existing land use pattern (agriculture, non-agriculture, forest, water bodies (including

area under CRZ)), shortest distances from the periphery of the project to periphery of the

forests, national park, wild life sanctuary, eco sensitive areas, water bodies (distance from

HFL of the river), CRZ. In case of the notified industrial area, a copy of the Gazette

notification should be given.

Existing land use pattern will be incorporated in the EIA Study. CRZ Clearance is not

applicable.

4.5 Existing Infrastructure

Existing operating industry having Production Area, Adm. Bldg., Parking, Raw Material

Storage, etc.

4.6 Soil Classification

Soil Classification will be incorporated in the EIA Study.

4.7 Climatic data from secondary sources.

Climatic data will be incorporated in the EIA Study.

4.8 Social infrastructure available.

Various Programs/ Projects related to Social & Economic development of surrounded area

has been planned, which are as follows.

A) Natural Resource Management – The main focus of this program will be to maximize the

yield returns of the farmers through efficient management of existing resources &

extension of new agricultural practices.

1) Integrated Agricultural Growth Project – For improvement and use of the modern

techniques and thereby would certainly contribute to prosperity in the agriculture

sector and reduce the rural poverty by programs like Farmers Training, Nursery

Growing Trainings, Modern agriculture equipment distribution programs etc.

23

2) Animal Husbandry Projects – Various programs like health checkups & treatment,

vaccination program, Anti sterility camps, breed improvement etc. will be carried

out.

B) Income Generation Program -

1) Establishment of Self help groups.

2) Rural Entrepreneurship Development Program

3) Handcrafts Development Program

4) Vocational Training

5) Business process outsourcing

C) Health, Education & Infrastructure

1) Aids Awareness Program

2) General Health Camps

3) Innovative Teaching Methods

4) Adult Education

5) Sanitation

6) Infrastructure Development Projects

5.0 Planning Brief

5.1 Planning Concept (type of industries, facilities, transportation etc) Town and Country

planning/Development authority classification.

Type of Industry: Proposed expansion of Bulk Drugs & Bulk drug Intermediates in existing

manufacturing unit.

5.2 Population Projection

Population Projection will be incorporated in the EIA Study

24

5.3 Land use planning (breakup along with green belt etc.)

SR. NO. PARTICULAR AREA (m2)

1 Production Area-I 800

2 Production Area-II 800

3 Raw Material Storage Area 500

4 Utility 100

5 Storage (Hazardous Chemical) 150

6 Hazardous Waste Storage Area 250

7 Effluent Treatment Plant 350

8 Green Belt 1900

9 Roads 50

10 Parking Area 50

11 Admin Block 100

12 Security Office 100

13 Clean Room Area 300

14 DM Plant 250

15 D.G. Room 100

Total 5800

5.4 Assessment of Infrastructure Demand (Physical & Social)

• Employment would be as per prevailing norms of state government for skilled and

unskilled people for the proposed expansion activity.

• Social Welfare

• Cordial relation with the villages shall be established and representation shall be made

to villagers for help for creation of facilities related to health, education, etc.

5.5 Amenities/Facilities

Details of amenities available in study area

Population Projection will be incorporated in the EIA Study

25

6.0 Proposed Infrastructure

6.1 Industrial Area (Processing Area)

Processing Area (Production Area, Utility , ETP Area, Admin Block, DM Plant, Security Office,

D.G.Room ) = 2,500 m2

6.2 Residential Area (Non Processing Area)

Non Processing Area (Raw material storage area, Storage (Hazardous Chemicals) area,

Hazardous waste storage Area, Clean room Area, Utility ,Road ,Parking Area ,green belt) =

3,300 m2

Green Belt: 1,900 m2

6.3 Green Belt

Total 5,800 sq. meter land area is available at site; out of this area around 1,900 sq. meter

(33%) area will be developed as greenbelt.

6.4 Social Infrastructure

• Water requirement will be met through GIDC Water Supply.

• Power supply by DGVCL.

6.5 Connectivity (Traffic and Transportation Road/ Rail/Metro/ Water ways etc)

Major factors involved in the selection of site are listed below:

• Site is very well connected by road

• Proximity to Raw Material suppliers

• Availability of sufficient land free from cultivation

• Availability of power facilities

• Availability of fuel

6.6 Drinking water Management (Source & Supply of water)

Total water requirement shall met through GIDC Water Supply.

26

6.7 Sewerage System

Sewage pipes are laid in entire company for the removal and disposal of mainly non-

harmful liquid wastes from the offices, canteen and domestic waste coming from different

section of industry. These liquid wastes are sent to septic tank & soak pit.

6.8 Solid Waste Management

Please refer Form-I, Annexure-VI.

6.9 Power Requirement & Supply/Source

Please refer Section 1.8, Page No. 13 of this report.

7.0 Rehabilitation and Resettlement (R & R) Plan

7.1 Policy to be adopted (central/state) in respect of the project affected including home

oustees, land oustees and landless laborers (a brief outline to be given)

There is no habitation on the proposed expansion project activity area and it is open

industrial land, so R & R policy is not applicable to this project.

There shall not be displacement of any population in project area. Any major activity that

may lead to resettlement of the people is considered as permanent impact. Hence, there is

no permanent impact on this account. The increasing industrial activity will boost the

commercial and economical status of the locality up to some extent.

8. Project Schedule & Cost Estimates

8.1 Likely date of start of construction and likely date of completion (Time schedule for

the project to be given).

We shall start construction of expansion project after getting EC & CTE and we shall start

production after applying for CCA.

27

8.2 Estimated Project cost along with analysis in terms of economic viability of the

project.

The total cost of the project after proposed expansion will be Rs. 5 Crores .

9. Analysis of Proposal (Final Recommendations)

9.1 Financial and social benefits with special emphasis on the benefit to be local people

including tribal population, if any, in the area.

• Employment would be as per prevailing norms of state government for skilled and

unskilled people for the proposed expansion project.

• Social Welfare shall be done.

• Cordial relation with the industry shall be established and representation shall be made

to villagers for help for creation of facilities related to health, education, etc.